European Investment Bank (HQ)

Apollo Pharma R&D (GFI)

Last update: Feb 26, 2015 Last update: Feb 26, 2015

Details

Location:GreeceGreece
Category:Consulting services
Status:Approval
Sectors:Health, Science & Innovation
Contracting Authority: Pharmathen S.A.
Contracting Authority Type:Private Sector
Eligibility:Unknown
Budget: EUR 50,000,000
Date posted: Nov 13, 2014

Attachments 1

Associated Awards

Project cycle timeline

STAGES
EARLY INTELLIGENCE
PROCUREMENT
IMPLEMENTATION
Cancelled
Status
Programming
Formulation
Approval
Forecast
Open
Closed
Shortlisted
Awarded
Evaluation

Associated tenders 0

Status

Date

Description

Promoter – Financial Intermediary Pharmathen SA Location Greece Description The project concerns the development of novel generic drugs using the group's proprietary technological expertise. Objectives Resea
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Learn more about our membership benefits
Similar tenders
By Locations
Funding agency:
EBRD
Status:
approval
Location:
Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Egypt, Estonia, Georgia, Greece, Hungary, Jordan, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Moldova, Mongolia, Montenegro, Morocco, North Macedonia, Palestine / West Bank & Gaza, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Tajikistan, Tunisia, Turkey, Turkmenistan, Ukraine, Uzbekistan
By Sectors
Funding agency:
EIB
Status:
approval
Location:
Spain
Funding agency:
EIB
Status:
approval
Location:
Denmark